Treace Medical Concepts Inc (OQ:TMCI)

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 100 Palmetto Park Place
PONTE VEDRA FL 32081
Tel: N/A
Website: https://www.treace.com
IR: See website
<
Key People
James T. Treace
Chairman of the Board
John T. Treace
Chief Executive Officer, Founder, Director
Mark L. Hair
Chief Financial Officer
Aaron J. Berutti
Senior Vice President - Sales
Nathan Minnich
Senior Vice President - Marketing
Scot Michael Elder
Chief Legal Officer, Chief Compliance Officer, Corporate Secretary
Julie D. Dewey
Chief Communications, Investor Relations Officer
Sean F. Scanlan
Chief Innovation Officer
 
Business Overview
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Financial Overview
For the fiscal year ended 31 December 2023, Treace Medical Concepts Inc revenues increased 32% to $187.1M. Net loss increased 16% to $49.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Sales and marketing - Balancing value increase of 39% to $120.2M (expense), General and administrative - Balancing increase of 28% to $36.5M (expense).
Employees: 516 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $567.75M as of Dec 31, 2023
Annual revenue (TTM): $187.12M as of Dec 31, 2023
EBITDA (TTM): -$46.00M as of Dec 31, 2023
Net annual income (TTM): -$49.53M as of Dec 31, 2023
Free cash flow (TTM): -$46.03M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 61,936,000 as of Mar 25, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.